期刊文献+

人胱抑素C单克隆抗体的制备、鉴定及初步应用 被引量:2

Preparation,characterization and preliminary application of monoclonal antibody against cystatin C
下载PDF
导出
摘要 目的:制备人胱抑素C(Cystatin C,Cys C)的单克隆抗体(McAb),并建立检测人血清Cys C的颗粒增强透射免疫浊度分析法(PETIA)。方法:构建人Cys C的原核表达载体pET32a(+)/Cys C,纯化Cys C重组蛋白并免疫BALB/c小鼠,杂交瘤技术制备Cys C的McAb;以自制的McAb包被乳胶颗粒,建立PETIA法测定血清Cys C,并对其分析性能进行初步方法学评价。结果:建立分泌抗Cys C单克隆抗体的杂交瘤细胞株3株,其分泌的McAb为IgG1,Western blot检测证实该抗体能与目的蛋白发生特异性结合;将杂交瘤细胞注射于小鼠腹腔,腹水中Cys C McAb效价为1∶4×106;用自制的McAb建立定量测定Cys C的PETIA,方法学评价试验结果证实我们建立的PETIA法,与进口试剂有很好的可比性,具有较满意的方法学性能。结论:成功制备了抗Cys C单克隆抗体,该抗体可用于建立定量检测Cys C的PETIA法。 Objective:To prepare monoclonal antibodies (McAb) against cystatin C (Cys C) and to estabhsh the particle enhanced turbidimetric immunoassay (PETIA) for determining human serum Cys C. Methods: The prokaryotic expression vector pET32a( + )/Cys C was constructed and Cys C expression was induced. McAbs against Cys C were prepared with the hybridoma technique after mice were immunized with the purified recombinant protein. Then the McAbs were covalently attached to uniform microparticles, PETIA method for determination of human serum Cys C was established,and primary evaluation tests of methodology were performed.Results: Three hybridoma cell lines were obtained successfully, the secreted antibodies were isotype of IgG1, and Western blot confirmed that the antibodies reacted specifically to the Cys C protein. After one of the hybridoma cell lines was injected into mice abdominal cavity, the ascites abundant for McAb was obtained. The titer of the McAb against the purified protein was 1 : 4 × 10^6. With the self-made McAb, PETIA for human serum Cys C was established. The primary evaluation tests of methodology revealed that self-established PE33A method had a satisfactory performance, which was equal to the import kit. Conclusion: The prepared McAb against Cys C is prepared, which could be used to establish PETIA for determining human serum Cys C.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2008年第9期828-830,共3页 Chinese Journal of Immunology
关键词 胱抑素C 单克隆抗体 颗粒增强透射免疫分析法 Cystatin C Monoclonal antibedy PETIA
  • 相关文献

参考文献6

  • 1Laterza O F, Price C P, Scott M G. Cystatin C:an improved estimator of glomerular filtration rate[J]. Clin Chem,2002;48(5) :699-707.
  • 2Coll E, Botey A, Alvarez L et al.Serum Cystatin C as a new maker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J] .AM J Kid Diseases,2000;36(1) :29-34.
  • 3Finney H, Newman D J, Gruber Wet al. Initial evaluation of cystatin C measurement by partite-enchanted immunonephlometry on the Behring Nephelometer systems(BNA, BN Ⅱ ) [ J]. Clin Chem, 1997;43 (6) : 1016- 1022.
  • 4Jan K A, Camilla S, Gtmnar N et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum ereatinine for glomerular filtration rate [ J ]. Clin Chem, 1994 ;40(10) : 1921-1926.
  • 5Pergande M, Jung K. Sandwich enzyme immunoassay for cystatin C in serum with commercially available antibodies[ J ]. Clin Chem, 1993; 39: 1885-1990.
  • 6Joronen I,Hopsu-Havu V K,Manninen M et al . Detection of low molecular weight cysteine proteinase inhibitory by time-resolved fluoroimmunoassay[ J]. J Immunol Methods, 1986; 86: 243-247.

同被引文献16

  • 1李海霞,吴红花,徐国宾,郭晓蕙,夏铁安.血清半胱氨酸蛋白酶抑制剂C与肌酐在评价糖尿病患者肾小球滤过功能中的比较研究[J].中华检验医学杂志,2005,28(6):602-605. 被引量:107
  • 2Filer G,Prien F, Vollmerl, et al. Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate[J]. Pediatr Nephrol, 2004,13 (6) : 501-505.
  • 3Randers E,Erlandsen EJ. Serum cystatin C as an endoge- nous marker of the renal function--a review[J]. Clin Chem Lab Med,1999,37(4) 389-395.
  • 4骆国军,宋绍忠,江山,廖磊,李雪冬,朱小广,杨耀.双光径免疫浊度分析仪测定8型肺炎球菌荚膜多糖[J].上海预防医学,2007,19(11):561-562. 被引量:6
  • 5WHO.Recommendations to assure the quality,safety and efficacy of pneumococcal conjugate vaccines[C].60th meeting of the WHO Expert Committee on Biological Standardization.Geneva,2009.
  • 6Yao KH,Yang YH.Streptococcus pneumoniae diseases in Chinese children:past,present and future[J].Vaccine,2008,26(35):4425-4433.
  • 7WHO.23-valent pneumococcal polysaccharide vaccine.WHO position paper[J].Wkly Epidemiol Rec,2008,83(42):373-384.
  • 8Nahm MH,Burton RL.Protocol for multiplexed opsonophagocytic killing assay(UAB-MOPA)for antibodies against Streptococcus pneumoniae[S/OL].www.vaccine.uba.edu.Version D.05.2013.
  • 9Beckman-Coulter Co.Ltd.IMMAGE用户使用手册[S].1999:132-155.
  • 10Lee CJ.The quantitative immunochemical determination of pneumococcal and meningococcal capsular polysaccharides by light scattering rate nephelometry[J].J Biol Stand,1983,11(1):55-64.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部